• Login
    View Item 
    •   DSpace Home
    • Students & Alumnae
    • Undergraduate Thesis
    • Faculty of Industrial Technology
    • Industrial Engineering
    • View Item
    •   DSpace Home
    • Students & Alumnae
    • Undergraduate Thesis
    • Faculty of Industrial Technology
    • Industrial Engineering
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Supply Chain Risk Management on Medicine Supply Using House Of Risk (HOR) and Value at Risk Method at RSUD Pandan Arang

    Thumbnail
    View/Open
    18522304.pdf (3.009Mb)
    Date
    2024
    Author
    Al Karimah, Nur Imamah
    Metadata
    Show full item record
    Abstract
    Hospitals, as defined by the World Health Organization, play a crucial role as essential components within medical and social structures, offering comprehensive healthcare services. The effective management of hospitals is of utmost importance, requiring enhancements in quality to fortify healthcare provisions. This investigation delves into the pivotal role of pharmacy installations in hospitals, underscoring their significance in pharmaceutical planning, supply, and oversight. The focus is on RSUD Pandan Arang, a government-owned hospital in Boyolali, Central Java, to assess the contribution of pharmaceutical installations in supporting diverse medical services, particularly those under BPJS. The study identifies inherent uncertainties in the future that pose risks to the overall business process, stressing the need for efficient drug supply chain management to ensure optimal service delivery, patient safety, and consultation availability. To address these challenges, the study employs the House of Risk (HOR) technique and the Value at Risk (VaR) method to identify, analyze, and mitigate potential hazards. Drawing on historical data, the study pinpoints 17 risk events and agents, with a focus on two high-risk, low- incidence primary agents: "lack of supervision of medicine by the head of the pharmacy department" and "lack of communication with distributors." Additionally, the VaR technique estimates potential financial impacts over a three-month period with a 95% confidence level, suggesting losses ranging from Rp 2,645,000.00 to Rp 183,522,609.07. These risks encompass inaccuracies in RAB calculations, forecasting issues, fluctuations in pharmaceutical prices, ordering errors, shortages, communication gaps, shipping negligence, quality control lapses, and extended return timeframes. The research concludes by highlighting the importance of implementing effective risk management measures.
    URI
    dspace.uii.ac.id/123456789/52127
    Collections
    • Industrial Engineering [2835]

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV